Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Methods for evaluating adverse drug event preventability in emergency department patients.

Woo SA, Cragg A, Wickham ME, Peddie D, Balka E, Scheuermeyer F, Villanyi D, Hohl CM.

BMC Med Res Methodol. 2018 Dec 4;18(1):160. doi: 10.1186/s12874-018-0617-4.

2.

Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset.

Peddie D, Small SS, Badke K, Bailey C, Balka E, Hohl CM.

JMIR Med Inform. 2018 Jun 28;6(2):e10248. doi: 10.2196/10248.

3.

Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug Events.

Hohl CM, Badke K, Zhao A, Wickham ME, Woo SA, Sivilotti MLA, Perry JJ.

Acad Emerg Med. 2018 Sep;25(9):1015-1026. doi: 10.1111/acem.13407.

4.

Why Clinicians Don't Report Adverse Drug Events: Qualitative Study.

Hohl CM, Small SS, Peddie D, Badke K, Bailey C, Balka E.

JMIR Public Health Surveill. 2018 Feb 27;4(1):e21. doi: 10.2196/publichealth.9282.

5.

Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol.

Cragg A, Hau JP, Woo SA, Liu C, Doyle-Waters MM, Hohl CM.

Syst Rev. 2017 Dec 28;6(1):265. doi: 10.1186/s13643-017-0642-0.

6.

Validation of the Ottawa Subarachnoid Hemorrhage Rule in patients with acute headache.

Perry JJ, Sivilotti MLA, Sutherland J, Hohl CM, Émond M, Calder LA, Vaillancourt C, Thirganasambandamoorthy V, Lesiuk H, Wells GA, Stiell IG.

CMAJ. 2017 Nov 13;189(45):E1379-E1385. doi: 10.1503/cmaj.170072. Erratum in: CMAJ. 2018 Feb 12;190(6):E173.

7.

Patient Perceptions About Data Sharing & Privacy: Insights from ActionADE.

Small SS, Peddie D, Ackerley C, Hohl CM, Balka E.

Stud Health Technol Inform. 2017;241:109-114.

PMID:
28809192
8.

Incidence of clinically relevant medication errors in the era of electronically prepopulated medication reconciliation forms: a retrospective chart review.

Stockton KR, Wickham ME, Lai S, Badke K, Dahri K, Villanyi D, Ho V, Hohl CM.

CMAJ Open. 2017 May 5;5(2):E345-E353. doi: 10.9778/cmajo.20170023.

9.

Impact of early in-hospital medication review by clinical pharmacists on health services utilization.

Hohl CM, Partovi N, Ghement I, Wickham ME, McGrail K, Reddekopp LN, Sobolev B.

PLoS One. 2017 Feb 13;12(2):e0170495. doi: 10.1371/journal.pone.0170495. eCollection 2017.

10.

Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record.

Chruscicki A, Badke K, Peddie D, Small S, Balka E, Hohl CM.

Springerplus. 2016 Oct 11;5(1):1764. eCollection 2016.

11.

Factors influencing time to computed tomography in emergency department patients with suspected subarachnoid haemorrhage.

Khan M, Sivilotti ML, Bullard MJ, Émond M, Sutherland J, Worster A, Hohl CM, Lee JS, Eisenhauer M, Pauls M, Lesiuk H, Wells GA, Stiell IG, Perry JJ.

Emerg Med J. 2017 Jan;34(1):20-26. doi: 10.1136/emermed-2016-205785. Epub 2016 Sep 22.

PMID:
27660386
12.

Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.

Peddie D, Small SS, Badke K, Wickham ME, Bailey C, Chruscicki A, Ackerley C, Balka E, Hohl CM.

JMIR Res Protoc. 2016 Aug 18;5(3):e169. doi: 10.2196/resprot.5967.

13.

Performance of trigger tools in identifying adverse drug events in emergency department patients: a validation study.

Karpov A, Parcero C, Mok CP, Panditha C, Yu E, Dempster L, Hohl CM.

Br J Clin Pharmacol. 2016 Oct;82(4):1048-57. doi: 10.1111/bcp.13032. Epub 2016 Jul 8.

14.

Adverse drug event reporting systems: a systematic review.

Bailey C, Peddie D, Wickham ME, Badke K, Small SS, Doyle-Waters MM, Balka E, Hohl CM.

Br J Clin Pharmacol. 2016 Jul;82(1):17-29. doi: 10.1111/bcp.12944. Epub 2016 May 9. Review.

15.

Delayed sequence intubation: is it ready for prime time?

Taylor JA, Hohl CM.

CJEM. 2017 Jan;19(1):68-70. doi: 10.1017/cem.2016.13. Epub 2016 Feb 25.

PMID:
26911672
16.

Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.

Hohl CM, Wong JK, Harlos MS.

J Palliat Care. 2015;31(2):124-6. No abstract available.

PMID:
26201215
17.

The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol.

Hohl CM, McGrail K, Sobolev B.

CMAJ Open. 2015 Jan 13;3(1):E103-10. doi: 10.9778/cmajo.20140010. eCollection 2015 Jan-Mar.

18.

The effect of early in-hospital medication review on health outcomes: a systematic review.

Hohl CM, Wickham ME, Sobolev B, Perry JJ, Sivilotti ML, Garrison S, Lang E, Brasher P, Doyle-Waters MM, Brar B, Rowe BH, Lexchin J, Holland R.

Br J Clin Pharmacol. 2015 Jul;80(1):51-61. doi: 10.1111/bcp.12585. Epub 2015 Jun 3. Review.

19.

The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review.

Cohen L, Athaide V, Wickham ME, Doyle-Waters MM, Rose NG, Hohl CM.

Ann Emerg Med. 2015 Jan;65(1):43-51.e2. doi: 10.1016/j.annemergmed.2014.06.018. Epub 2014 Jul 23. Review.

PMID:
25064742
20.

Methotrimeprazine for the management of end-of-life symptoms in infants and children.

Hohl CM, Stenekes S, Harlos MS, Shepherd E, McClement S, Chochinov HM.

J Palliat Care. 2013 Autumn;29(3):178-85.

PMID:
24380217
21.

ICD-10 codes used to identify adverse drug events in administrative data: a systematic review.

Hohl CM, Karpov A, Reddekopp L, Doyle-Waters M, Stausberg J.

J Am Med Inform Assoc. 2014 May-Jun;21(3):547-57. doi: 10.1136/amiajnl-2013-002116. Epub 2013 Nov 12. Review. Erratum in: J Am Med Inform Assoc. 2014 Jul-Aug;21(4):757. Doyle-Waters, Mimi [added].

22.

Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study.

Hohl CM, Kuramoto L, Yu E, Rogula B, Stausberg J, Sobolev B.

BMC Health Serv Res. 2013 Nov 12;13:473. doi: 10.1186/1472-6963-13-473.

23.

Clinical decision rules to rule out subarachnoid hemorrhage for acute headache.

Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Hohl CM, Sutherland J, Émond M, Worster A, Lee JS, Mackey D, Pauls M, Lesiuk H, Symington C, Wells GA.

JAMA. 2013 Sep 25;310(12):1248-55. doi: 10.1001/jama.2013.278018.

PMID:
24065011
24.

Clinical decision rules to improve the detection of adverse drug events in emergency department patients.

Hohl CM, Yu E, Hunte GS, Brubacher JR, Hosseini F, Argent CP, Chan WW, Wiens MO, Sheps SB, Singer J.

Acad Emerg Med. 2012 Jun;19(6):640-9. doi: 10.1111/j.1553-2712.2012.01379.x.

25.

Emergency hospitalizations for adverse drug events.

Hohl CM, de Lemos J, Abu Laban RB.

N Engl J Med. 2012 Mar 1;366(9):858-9; author reply 859-60. doi: 10.1056/NEJMc1114768. No abstract available.

PMID:
22375984
26.

Outcomes of emergency department patients presenting with adverse drug events.

Hohl CM, Nosyk B, Kuramoto L, Zed PJ, Brubacher JR, Abu-Laban RB, Sheps SB, Sobolev B.

Ann Emerg Med. 2011 Sep;58(3):270-279.e4. doi: 10.1016/j.annemergmed.2011.01.003. Epub 2011 Feb 26.

PMID:
21354651
27.

Patient-reported adverse drug-related events from emergency department discharge prescriptions.

Hohl CM, Abu-Laban RB, Zed PJ, Brubacher JR, Tsai G, Kretz P, Nemethy K, Purssell RA.

CJEM. 2010 Jul;12(4):331-8.

PMID:
20650026
28.

The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review.

Hohl CM, Kelly-Smith CH, Yeung TC, Sweet DD, Doyle-Waters MM, Schulzer M.

Ann Emerg Med. 2010 Aug;56(2):105-13.e5. doi: 10.1016/j.annemergmed.2010.01.030. Epub 2010 Mar 25. Review.

PMID:
20346542
29.

Do emergency physicians attribute drug-related emergency department visits to medication-related problems?

Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA.

Ann Emerg Med. 2010 Jun;55(6):493-502.e4. doi: 10.1016/j.annemergmed.2009.10.008. Epub 2009 Dec 11.

PMID:
20005010
30.

Adherence to emergency department discharge prescriptions.

Hohl CM, Abu-Laban RB, Brubacher JR, Zed PJ, Sobolev B, Tsai G, Kretz P, Nemethy K, Bijlsma JJ, Purssell RA.

CJEM. 2009 Mar;11(2):131-8.

PMID:
19272214
31.

Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Wiens MO, Samoy LJ, Lacaria K, Purssell RA.

CMAJ. 2008 Jun 3;178(12):1563-9. doi: 10.1503/cmaj.071594.

32.

A cost-effectiveness analysis of propofol versus midazolam for procedural sedation in the emergency department.

Hohl CM, Nosyk B, Sadatsafavi M, Anis AH.

Acad Emerg Med. 2008 Jan;15(1):32-9. doi: 10.1111/j.1553-2712.2007.00023.x. Erratum in: Acad Emerg Med. 2008 Mar;15(3):304.

33.

Safety and clinical effectiveness of midazolam versus propofol for procedural sedation in the emergency department: a systematic review.

Hohl CM, Sadatsafavi M, Nosyk B, Anis AH.

Acad Emerg Med. 2008 Jan;15(1):1-8. doi: 10.1111/j.1553-2712.2007.00022.x. Review.

34.

Should emergency physicians use B-type natriuretic peptide testing in patients with unexplained dyspnea?

Hohl CM, Mitelman BY, Wyer P, Lang E.

CJEM. 2003 May;5(3):162-5. No abstract available.

PMID:
17472780
35.

Should natriuretic peptide testing be incorporated into emergency medicine practice?

Hohl CM.

CJEM. 2006 Jul;8(4):259-61. No abstract available.

PMID:
17324305
36.

Effects of wind direction on coarse and fine particulate matter concentrations in southeast Kansas.

Guerra SA, Lane DD, Marotz GA, Carter RE, Hohl CM, Baldauf RW.

J Air Waste Manag Assoc. 2006 Nov;56(11):1525-31.

PMID:
17117737
37.

Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department.

Hohl CM, Robitaille C, Lord V, Dankoff J, Colacone A, Pham L, Bérard A, Pépin J, Afilalo M.

Acad Emerg Med. 2005 Mar;12(3):197-205.

38.
39.

Isolation and regulation of piglet cardiac AMP deaminase.

Hohl AM, Hohl CM.

Mol Cell Biochem. 1999 Nov;201(1-2):151-8.

PMID:
10630634
40.

FK506 alters sarcoplasmic reticulum calcium release in neonatal piglet cardiac myocytes.

Hohl CM, Altschuld RA.

Pediatr Res. 1999 Sep;46(3):316-9.

PMID:
10473047
41.

AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia.

Hohl CM.

Am J Physiol. 1999 May;276(5):H1502-10. doi: 10.1152/ajpheart.1999.276.5.H1502.

PMID:
10330232
42.

Thiol redox modulation of doxorubicin mediated cytotoxicity in cultured AIDS-related Kaposi's sarcoma cells.

Mallery SR, Clark YM, Ness GM, Minshawi OM, Pei P, Hohl CM.

J Cell Biochem. 1999 May 1;73(2):259-77.

PMID:
10227389
43.

Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia.

Litsky ML, Hohl CM, Lucas JH, Jurkowitz MS.

Brain Res. 1999 Mar 13;821(2):426-32.

PMID:
10064830
45.

Thiol redox modulation of tumor necrosis factor-alpha responsiveness in cultured AIDS-related Kaposi's sarcoma cells.

Mallery SR, Landwehr DJ, Ness GM, Clark YM, Hohl CM.

J Cell Biochem. 1998 Mar 1;68(3):339-54.

PMID:
9518260
47.

Calcium handling by sarcoplasmic reticulum of neonatal swine cardiac myocytes.

Hohl CM, Livingston B, Hensley J, Altschuld RA.

Am J Physiol. 1997 Jul;273(1 Pt 2):H192-9.

PMID:
9249490
48.

Verapamil accelerates the transition to heart failure in obese, hypertensive, female SHHF/Mcc-fa(cp) rats.

Park S, McCune SA, Radin MJ, Hoepf TM, Hensley J, Hohl CM, Altschuld RA.

J Cardiovasc Pharmacol. 1997 Jun;29(6):726-33.

PMID:
9234652
49.

Effects of calcium channel antagonists on Ca2+ transients in rat and canine cardiomyocytes.

Hensley J, Billman GE, Johnson JD, Hohl CM, Altschuld RA.

J Mol Cell Cardiol. 1997 Mar;29(3):1037-43.

PMID:
9152864
50.

Metabolic compartmentalization in neonatal swine myocytes.

Livingston BE, Altschuld RA, Hohl CM.

Pediatr Res. 1996 Jul;40(1):59-65.

PMID:
8798247

Supplemental Content

Support Center